---
title: "Lepu Medical Technology (Beijing) Co., Ltd. (300003.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300003.SZ.md"
symbol: "300003.SZ"
name: "Lepu Medical Technology (Beijing) Co., Ltd."
industry: "Health Care Equipment"
datetime: "2026-05-20T22:34:13.900Z"
locales:
  - [en](https://longbridge.com/en/quote/300003.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300003.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300003.SZ.md)
---

# Lepu Medical Technology (Beijing) Co., Ltd. (300003.SZ)

## Company Overview

Lepu Medical Technology (Beijing) Co., Ltd., together with its subsidiaries, engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally. The company operates through three segments: Medical Devices; Pharmaceuticals; and Medical Services and Health Management. It offers medical devices, including cardiovascular devices, in vitro diagnostics, surgical instruments, peripheral blood vessels, blood purification, ultrasound imaging, and orthopedic products; pharmaceutical products for cardiovascular, digestive, central nervous, and respiratory systems, as well as antimicrobial, nutrition, traditional Chinese medicine, lowering blood sugar, and health food; and medical services and health management, such as medical services, AI, home appliances, and medical aesthetics and daily chemical products. The company is also involved in investment activities; trading; technological development; and pension services.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.lepumedical.com](https://www.lepumedical.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: C (0.41)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 35 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 8.47% |  |
| Net Profit YoY | 478.16% |  |
| P/B Ratio | 1.52 |  |
| Dividend Ratio | 2.20% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 25041301164.59 |  |
| Revenue | 6429978343.93 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 5.18% | C |
| Profit Margin | 12.94% | B |
| Gross Margin | 62.03% | A |
| Revenue YoY | 8.47% | B |
| Net Profit YoY | 478.16% | A |
| Total Assets YoY | 1.40% | C |
| Net Assets YoY | 4.76% | C |
| Cash Flow Margin | 165.34% | B |
| OCF YoY | 8.47% | B |
| Turnover | 0.25 | D |
| Gearing Ratio | 29.75% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Lepu Medical Technology (Beijing) Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "8.47%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "478.16%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.52",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "2.20%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "25041301164.59",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "6429978343.93",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "5.18%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "12.94%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "62.03%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "8.47%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "478.16%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "1.40%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "4.76%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "165.34%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "8.47%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.25",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "29.75%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 29.42 | 13/64 | 169.46 | 79.60 | 69.40 |
| PB | 1.49 | 7/64 | 2.19 | 2.02 | 1.84 |
| PS (TTM) | 3.81 | 13/64 | 5.47 | 4.96 | 4.57 |
| Dividend Yield | 2.25% | 13/64 | 1.92% | 1.76% | 1.62% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-17T16:00:00.000Z

Total Analysts: **8**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 6 | 75% |
| Hold | 2 | 25% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 13.25 |
| Highest Target | 24.00 |
| Lowest Target | 16.40 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300003.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300003.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300003.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300003.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**